A Multicenter, Non-Interventional Prospective Active Surveillance Study Among Participants Receiving Somatrogon Under Routine Clinical Care In India (Bengaluru)

A Multicenter, Non-Interventional Prospective Active Surveillance Study Among Participants Receiving Somatrogon Under Routine Clinical Care In India (Bengaluru)

10 Aug
|
DecenTrialz
|
Bengaluru

10 Aug

DecenTrialz

Bengaluru

Actively Recruiting

Age: 3Years - 17Years

All Genders

ID06587035

A Multicenter, Non-interventional Prospective Active Surveillance Study Among Participants Receiving Somatrogon Under Routine Clinical Care in India

Led by Pfizer

Updated on 2026-06-05

50

Participants Needed

4

Research Sites

102 weeks

Total Duration

On this page

AI-Summary

Brief Title

Who Can Participate

AI-Screening

Trial Site Locations

Research Team

How is the study designed?

AI-Summary

What This Trial Is About

The purpose of this study is to learn about the safety of Somatrogon for the treatment of pediatric growth hormone deficiency (p GHD) in India. Pediatric GHD is a condition caused by too less amounts of growth hormone in the body. Children with GHD have a short height. GHD can be present at birth or develop later. The condition occurs if the pituitary gland makes too little growth hormone. This is a small gland at the bottom of the brain that releases hormones that affect growth and other body functions. This study is seeking for participants who are:



* confirmed with p GHD. * given Somatrogon to be taken as an injection. The safety of Somatrogon injection will be checked based on side effects. These side effects can happen within 3 years after taking Somatrogon. A side effect is something (expected or unexpected) that you feel was caused by a medicine or treatment you take. The study doctor will collect side effect information and put the information on patient's case form. Follow-up of the patient's will be performed via clinic re-visit or over a call. It is not a rule for the participants to visit the clinic in this study. This study will help to see if Somatrogon is protected.

CONDITIONS

Brief Title

A Study to Learn About Somatrogon in Patients With Pediatric Growth Hormone Deficiency (p GHD) in India.

Who Can Participate

Age: 3Years - 17Years

All Genders

Eligibility Criteria

Inclusion Criteria

Prescription of Somatrogon for p GHD in participants aged 3 years or

📌 A Multicenter, Non-Interventional Prospective Active Surveillance Study Among Participants Receiving Somatrogon Under Routine Clinical Care In India (Bengaluru)
🏢 DecenTrialz
📍 Bengaluru

Reply to this offer

Impress this employer describing Your skills and abilities, fill out the form below and leave Your personal touch in the presentation letter.

Subscribe to this job alert:

Get the latest job offers by email for: a multicenter, non-interventional prospective active surveillance study among participants receiving somatrogon under routine clinical care in india (bengaluru) / bengaluru

Subscribe to this job alert:

Get the latest job offers by email for: a multicenter, non-interventional prospective active surveillance study among participants receiving somatrogon under routine clinical care in india (bengaluru) / bengaluru